elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34167942-F9BDFA23-164A-496D-9054-3F0D88DB745D
Q34167942-F9BDFA23-164A-496D-9054-3F0D88DB745D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34167942-F9BDFA23-164A-496D-9054-3F0D88DB745D
Design, synthesis, and pharmacological characterization of novel spirocyclic quinuclidinyl-Δ2-isoxazoline derivatives as potent and selective agonists of α7 nicotinic acetylcholine receptors.
P2860
Q34167942-F9BDFA23-164A-496D-9054-3F0D88DB745D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34167942-F9BDFA23-164A-496D-9054-3F0D88DB745D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
81b1260e2aaa16c9f8acbd2d7d6e3c18e9eeee49
P2860
Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide)